These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes. Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685 [TBL] [Abstract][Full Text] [Related]
3. [New developments in asthma therapy: how do individual leukotriene antagonists work?]. Wagener M Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455 [TBL] [Abstract][Full Text] [Related]
4. [New drugs in asthma treatment. Leukotriene receptor blockers and leukotriene synthesis inhibitors]. Männistö J; Haahtela T Nord Med; 1997 Apr; 112(4):122-5. PubMed ID: 9198809 [TBL] [Abstract][Full Text] [Related]
5. Thromboxane A2 inhibition: therapeutic potential in bronchial asthma. Dogné JM; de Leval X; Benoit P; Delarge J; Masereel B Am J Respir Med; 2002; 1(1):11-7. PubMed ID: 14720071 [TBL] [Abstract][Full Text] [Related]
6. Anti-leukotriene agents: a new direction in asthma therapy. Nathan RA J Asthma; 1996; 33(6):353-66. PubMed ID: 8968291 [TBL] [Abstract][Full Text] [Related]
7. Role of leukotrienes in asthma. Henderson WR Ann Allergy; 1994 Mar; 72(3):272-8. PubMed ID: 8129221 [TBL] [Abstract][Full Text] [Related]
8. [Role of peptide-leukotrienes in bronchial asthma]. Kohno S Nihon Yakurigaku Zasshi; 1998 Apr; 111(4):223-31. PubMed ID: 9618707 [TBL] [Abstract][Full Text] [Related]
9. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma. Devillier P; Baccard N; Advenier C Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985 [TBL] [Abstract][Full Text] [Related]
11. Leukotrienes in asthma. The potential therapeutic role of antileukotriene agents. Smith LJ Arch Intern Med; 1996 Oct; 156(19):2181-9. PubMed ID: 8885816 [TBL] [Abstract][Full Text] [Related]
12. Anti-leukotriene intervention: is there adequate information for clinical use in asthma? Ind PW Respir Med; 1996 Nov; 90(10):575-86. PubMed ID: 8959114 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma. Drazen JM Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of thromboxane inhibitors in asthma. Dogné JM; de Leval X; Benoit P; Rolin S; Pirotte B; Masereel B Expert Opin Investig Drugs; 2002 Feb; 11(2):275-81. PubMed ID: 11829716 [TBL] [Abstract][Full Text] [Related]
18. Antileukotriene treatment in children with asthma--new patents. Stelmach I; Grzelewski T Recent Pat Inflamm Allergy Drug Discov; 2008 Nov; 2(3):202-11. PubMed ID: 19076010 [TBL] [Abstract][Full Text] [Related]
19. The role of leukotrienes and prostaglandins in asthma: evidence from clinical investigations. Robinson C; Holgate ST Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():209-16. PubMed ID: 2144694 [No Abstract] [Full Text] [Related]
20. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Salvi SS; Krishna MT; Sampson AP; Holgate ST Chest; 2001 May; 119(5):1533-46. PubMed ID: 11348965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]